G_hyperkalemia_web How much do your patients know about the dangers of high potassium levels in the body? They may know that potassium is good for you, or that you need specific levels of it in the ...
senior man_TS_519664464 KDQOL and EuroQol-5D-3L responses show worse quality of life among kidney disease patients who develop hyperkalemia. WASHINGTON—Hyperkalemia reduces the quality of life of ...
Please provide your email address to receive an email when new articles are posted on . The National Kidney Foundation launched a public education video series about hyperkalemia for patients with ...
Those with chronic kidney disease, heart failure, diabetes, and hypertension bear an increased burden of hyperkalemia. Untreated hyperkalemia can lead to life-threatening neuromuscular and cardiac ...
Hyperkalemia treatment trends in the ED are varied and inconsistent, depending on potassium levels when patients reach the ED. Although various treatments decreased potassium over 4 hours, only ...
Postoperative hyperkalemia is an important complication of adrenalectomy for aldosterone-producing adenoma. Recently, postoperative hyperkalemia has been found to have a relatively high incidence ...
Hyperkalemia is a potentially serious condition that can result in life-threatening cardiac arrhythmias and is associated with an increased mortality risk. Patients older than 65 years who have an ...
Verywell Health on MSN
Potassium Blood Test: Purpose and Interpretation
A potassium blood test is used to measure the amount of potassium in your blood. It is part of a panel of blood tests called ...
MINNEAPOLIS — A reduced risk for death may balance out concerns about hyperkalemia when treating heart failure with renin-angiotensin system (RAS) inhibitors and mineralocorticoid receptor antagonists ...
Please provide your email address to receive an email when new articles are posted on . Patients with a urine albumin-creatinine ratio of at least 3,500 mg/g had high rates of hyperkalemia. High rates ...
In patients with type 2 diabetes (T2D), the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with lower rates of hyperkalemia and sustained use of guideline-recommended renin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results